Novartis CEO says it won't join weight-loss drug frenzy
The CEO of Novartis The Swiss pharmaceutical giant has no intention of getting into the “frenzy” of weight loss drugs,…
The CEO of Novartis The Swiss pharmaceutical giant has no intention of getting into the “frenzy” of weight loss drugs,…
Headquarters of Roche, a multinational pharmaceutical industry on December 27, 2021 in Madrid, Spain. Cristina Arias | Cover | Getty…
A sign with the company logo is displayed outside Eli Lilly headquarters in Indianapolis, Indiana, March 17, 2024. Scott Olson…
Slimming syringes of the brands “Wegovy”, “Ozempic” and “Mounjaro” are sold at In der Achat Apotheke in Mitte, Germany. Image…
A sign with the company logo is displayed outside the headquarters of Eli Lilly and Company in Indianapolis, Indiana, on…
An injection pen for Eli Lilly's weight-loss drug Zepbound is displayed in New York City on December 11, 2023. Brendan…
Healthcare marketplace Sesame announced Wednesday a new clinical weight loss program that will help eligible consumers access compounded versions of…
An Eli Lilly & Co. Zepbound injection pen is prepared in the Brooklyn borough of New York, U.S., on Thursday,…
U.S. President Joe Biden and Vice President Kamala Harris walk together at an event on Medicare drug pricing negotiations in…
Activists protest prescription drug prices in front of the U.S. Department of Health and Human Services building in Washington, DC,…